Pharmacogenetics, pharmacogenomics and ecogenetics
- PMID: 16421980
- PMCID: PMC1363768
- DOI: 10.1631/jzus.2006.B0169
Pharmacogenetics, pharmacogenomics and ecogenetics
Abstract
Pharmacogenetics and pharmacogenomics deal with the role of genetic factors in drug effectiveness and adverse drug reactions. The promise of a personalized medicine is beginning to be explored but requires much more clinical and translational research. Specific DNA abnormalities in some cancers already have led to effective targeted treatments. Racially determined frequency differences in pharmacogenetic traits may affect choice of treatment requiring specific testing rather than basing treatments according to racial designation. The role of genes in variable responses to foreign chemicals (xenobiotics) has been termed ecogenetics or toxicogenetics raising problems in public health and occupational medicine. Nutrigenetics refers to genetic variation in response to nutrients and may affect nutritional requirements and predisposition to chronic disease.
References
-
- Motulsky AG. Drug reactions, enzymes and biochemical genetics. Journal of the American Medical Association. 1957;165:835–837. - PubMed
-
- Motulsky AG. human genetic variation and nutrition. American Journal of Clinical Nutrition. 1987;45:1108–1113. - PubMed
-
- Motulsky AG. from pharmacogenetics and ecogenetics to pharmacogenomics. Medicina nei Secoli Arte e Scienza (Journal of history of Medicine) 2002;14:683–705. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
